Mechanisms & risk factors of chronic lung disease in HIV+ adolescents in Nairobi
机制
基本信息
- 批准号:10467934
- 负责人:
- 金额:$ 7.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-02-15 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAdministrative SupplementAdolescenceAdolescentAdolescent and Young AdultAdultAerosolsAir PollutionBiological MarkersBronchiolitisCOVID-19COVID-19 pandemicCOVID-19 testingCOVID-19 vaccinationCatchment AreaChestChildChronicChronic lung diseaseClinicalClinical DataCommunicable DiseasesComplexComplicationCoughingCountryDataData CollectionData SetDevelopmentDiagnosisDisease ProgressionExposure toForced expiratory volume functionFundingFutureGeographyGrowthGrowth and Development functionHIVHIV InfectionsImmune System DiseasesImmunologic MarkersImpairmentIncomeInflammationInfrastructureInhalation ExposureInterventionKenyaLightLiteratureLongitudinal StudiesLungLung diseasesLung infectionsMachine LearningMeasuresMosaicismNatural HistoryParentsParticipantPathway interactionsPatternPediatric HIV/AIDS Cohort StudyPhenotypePopulationPositioning AttributeProceduresPublishingPulmonary Function Test/Forced Expiratory Volume 1Pulmonary PathologyResearchResolutionResourcesRespiratory Signs and SymptomsRiskRisk FactorsRoleSARS-CoV-2 infectionSafetyScheduleSerologySerumSpirometryStatistical Data InterpretationTestingTherapeutic InterventionTimeUnited States National Institutes of HealthVisitVulnerable PopulationsWorkX-Ray Computed Tomographyantibody testattenuationbasechest computed tomographycohortenvironmental tobacco smokeexperiencefine particlesfollow-upimmune activationinnovationinsightlow and middle-income countrieslung maturationnovelperinatal HIVpersonal protective equipmentpreventive interventionprimary outcomepulmonary functionrespiratoryyoung adult
项目摘要
PROJECT SUMMARY/ABSTRACT
As increasing numbers of children with HIV are surviving to adolescence in low- and middle-income countries,
chronic lung disease (CLD) has emerged as an important but poorly understood complication amongst
adolescents and young adults living with HIV (ALWH). In the ongoing, longitudinal BREATHE II Study (K23
HL129888, PI Attia) in Nairobi, Kenya, 19% of 162 ALWH have abnormal spirometry compared to 11% of 162
uninfected participants; 59% of ALWH have ≥1 abnormality on high-resolution chest CT scan, with mosaic
attenuation among the most common. Chronic respiratory symptoms are also highly prevalent among 62% of
ALWH and 49% of uninfected participants. HIV is independently associated with impaired lung function, and
risk factors for impaired spirometry among ALWH include inhaled exposures, such as secondhand smoke and
ambient fine particulate matter, as well as growth deficits. Objectives of the K23 research include: examining
differences in risk factors and mechanisms of CLD progression over time; determining the role of HIV infection
on change in lung function over time, considering the complex interplay with other risk factors; and, evaluating
whether biomarkers of chronic immune activation and inflammation are associated with diminished lung
function growth over time. However, in light of the COVID-19 pandemic, these longitudinal studies have been
halted for safety reasons. As these studies can now resume with added precautions, an Administrative
Supplement to this K23 will provide essential resources for the following Aims: 1) complete longitudinal lung
function and clinical data collection to conduct planned analyses as proposed in the parent K23; 2) add testing
for COVID-19 both to mitigate risk of potential spread of SARS-CoV-2 through spirometry (rapid PCR test) and
to examine the role of COVID-19 infection on lung function growth and development (serologic antibody test).
The indispensable support of this Supplement will maintain the BREATHE II cohort, a unique and innovative
resource for understanding CLD progression among ALWH, especially those with perinatal HIV acquisition,
compared to demographically similar uninfected participants from the same geographic catchment area in the
context of COVID-19. This cohort includes a dataset of chest CTs that is larger than in any published literature
to date. Serum for biomarker analysis (currently underway) has the potential to inform mechanistic pathways of
CLD. The study infrastructure is already supporting implementation of sub-studies to obtain quantitative
measures of air pollution exposure and to compare CLD in BREATHE II to a cohort of ALWH in a high-income
setting, and is a well-positioned platform to support future sub-studies. Findings of this research will provide
critical data for informing R01-level research to investigate novel insights into the pathophysiologic
mechanisms of CLD progression in ALWH in resource-limited settings, shedding light on risk factors and
mechanisms that can be targeted by preventative and therapeutic interventions to mitigate the burden of CLD.
项目摘要/摘要
随着艾滋病毒越来越多的儿童在低收入和中等收入国家中生存,
慢性肺病(CLD)已成为重要但知之甚少的并发症
青少年和艾滋病毒(ALWH)的年轻人。在正在进行的纵向呼吸II研究中(K23
肯尼亚内罗毕的HL129888,PI ATTIA),162 ALWH的19%具有异常的肺活量测定法
未感染的参与者;在高分辨率的胸部CT扫描中,有59%的ALWH绝对具有≥1的绝对功率,并带有马赛克
最常见的衰减。慢性呼吸道症状也很普遍
ALWH和49%的未感染参与者。 HIV与肺功能受损独立相关,并且
ALWH中肺活量测量受损的危险因素包括包括暴露,例如二手烟和
环境良好的特定物质以及增长不足。 K23研究的目标包括:检查
随着时间的流逝,CLD进展的危险因素和机制的差异;确定HIV感染的作用
考虑到与其他风险因素的复杂相互作用,肺功能随着时间的变化而变化;并评估
慢性免疫激活和炎症的生物标志物是否与肺部降低有关
随着时间的推移功能增长。然而,鉴于199年的大流行,这些纵向研究已经
出于安全原因停止。由于这些研究现在可以通过额外的预防措施恢复,因此
对此K23的补充将为以下目的提供基本资源:1)完整的纵向肺
功能和临床数据收集以进行父k23中提出的计划分析; 2)添加测试
对于COVID-19,既可以减轻SARS-COV-2通过肺活量测定法(快速PCR测试)和
检查Covid-19感染对肺功能生长和发育的作用(血清学抗体测试)。
这种补充的必不可少的支持将保持呼吸II队列,这是一个独特而创新的
理解ALWH中CLD进展的资源,尤其是那些患有围产期HIV的人,
与来自人口统计学相似的未感染的参与者相比
Covid-19的背景。该队列包含一个比任何已发表文献大的胸部CT数据集
迄今为止。生物标志物分析的血清(目前正在进行)有可能为机械途径提供信息
Cld。研究基础设施已经支持实施子研究以获得定量
空气污染暴露的度量并将呼吸II中的CLD与高收入中的ALWH进行比较
设置,是一个良好的平台,可以支持未来的子培训。这项研究的结果将提供
用于告知R01级研究的关键数据,以研究对病理生理学的新见解
在资源有限的设置中,ALWH中CLD进展的机制,阐明了风险因素和
可以通过预防和治疗干预措施来靶向的机制来减轻CLD的燃烧。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Engi Farouk Attia其他文献
Engi Farouk Attia的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Engi Farouk Attia', 18)}}的其他基金
Characterizing chronic lung disease in youth living with HIV: quantitative chest CT analyses
描述青年艾滋病毒感染者慢性肺部疾病的特征:定量胸部 CT 分析
- 批准号:
10541238 - 财政年份:2022
- 资助金额:
$ 7.91万 - 项目类别:
Characterizing chronic lung disease in youth living with HIV: quantitative chest CT analyses
描述青年艾滋病毒感染者慢性肺部疾病的特征:定量胸部 CT 分析
- 批准号:
10402042 - 财政年份:2022
- 资助金额:
$ 7.91万 - 项目类别:
Mechanisms & risk factors of chronic lung disease in HIV+ adolescents in Nairobi
机制
- 批准号:
10392286 - 财政年份:2021
- 资助金额:
$ 7.91万 - 项目类别:
Mechanisms & risk factors of chronic lung disease in HIV+ adolescents in Nairobi
机制
- 批准号:
9431238 - 财政年份:2017
- 资助金额:
$ 7.91万 - 项目类别:
Mechanisms & risk factors of chronic lung disease in HIV+ adolescents in Nairobi
机制
- 批准号:
9270386 - 财政年份:2017
- 资助金额:
$ 7.91万 - 项目类别:
Risk Factors for Abnormal Spirometry Among HIV+ Individuals in Nairobi, Kenya
肯尼亚内罗毕艾滋病毒感染者肺活量测定异常的危险因素
- 批准号:
8788893 - 财政年份:2014
- 资助金额:
$ 7.91万 - 项目类别:
相似海外基金
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)Scientific Leadership Center; ADMIN SUPPLEMENT
艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 科学领导中心;
- 批准号:
10855435 - 财政年份:2023
- 资助金额:
$ 7.91万 - 项目类别:
National Consortium on Alcohol and NeuroDevelopment in Adolescence (NCANDA): Administrative Resource
国家青少年酒精与神经发育联盟 (NCANDA):行政资源
- 批准号:
10888826 - 财政年份:2023
- 资助金额:
$ 7.91万 - 项目类别:
Developmental trajectory of anxiety, avoidance, and arousal in girls with the FMR1 full mutation
FMR1 完全突变女孩的焦虑、回避和觉醒的发展轨迹
- 批准号:
10576763 - 财政年份:2022
- 资助金额:
$ 7.91万 - 项目类别:
Threat-Related Negative Valence Systems, Child Victimization, and Anxiety_Supplement
与威胁相关的负价系统、儿童受害和焦虑_补充
- 批准号:
10597417 - 财政年份:2022
- 资助金额:
$ 7.91万 - 项目类别:
F32 Administrative Supplement for Childcare Costs
F32 儿童保育费用行政补助
- 批准号:
10578122 - 财政年份:2022
- 资助金额:
$ 7.91万 - 项目类别: